Replacement of prolonged-acting octreotide with lanreotide autogel 120 mg in patients with Acromegaly in real clinical practice

U. A. Tsoy; E. N. Kravchuk; A. B. Dalmatova; L. V. Belousova; E. N. Grineva

Meditsinskiy sovet = Medical Council
Meditsinskiy sovet

ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)

User

eng | рус

Meditsinskiy sovet = Medical Council

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Tsoy UA, Kravchuk EN, Dalmatova AB, Belousova LV, Grineva EN. Replacement of prolonged-acting octreotide with lanreotide autogel 120 mg in patients with Acromegaly in real clinical practice. Meditsinskiy sovet = Medical Council. 2022;(10):115-122. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-10-115-122

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)

Editor-in-Chief

Aydar A. Ishmukhametov

* not an advertisement

По рекомендации Президиума ВАК от 8 декабря 2023 г. № 31/1-разн

"О категорировании перечня рецензируемых научных изданий, в которых должны быть опубликованы основные научные результаты диссертаций на соискание ученой степени кандидата наук, на соискание ученой степени доктора наук" журналу «Медицинский совет» присвоена категория К1

Popular articles

Indexing Databases

* not an advertisement

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

U. A. Tsoy
Almazov National Medical Research Centre
Russian Federation

Uliana A. Tsoy, Cand. Sci. (Med.), Head of Research Laboratory of Neuroendocrine Tumours, Centre for Personalized Medicine